What is the differential diagnosis and initial management for a soft, mobile, minimally painful 4 cm × 3 cm axillary mass in a 3‑year‑old boy with a chest radiograph showing bronchiolitis and no other findings?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Differential Diagnosis of Axillary Mass in a 3-Year-Old

The most likely diagnosis is reactive lymphadenopathy secondary to the concurrent bronchiolitis, but you must rule out infectious lymphadenitis (especially bacterial or mycobacterial), lymphangioma, and less commonly lipoma or accessory breast tissue through ultrasound evaluation and possible aspiration if the mass persists beyond resolution of the respiratory illness. 1

Primary Differential Considerations

Reactive Lymphadenopathy (Most Likely)

  • Viral bronchiolitis commonly causes regional lymph node enlargement, and axillary lymphadenopathy can occur as part of the systemic immune response to respiratory viral infections 2
  • The soft, mobile characteristics with minimal pain are consistent with reactive lymph nodes rather than malignant or suppurative processes 1
  • The concurrent bronchiolitis on chest X-ray strongly supports this as a reactive phenomenon 2

Infectious Lymphadenitis

  • Bacterial lymphadenitis (Staphylococcus aureus, Streptococcus pyogenes) presents with tender, mobile lymph nodes but typically shows more pain and possible overlying skin changes 3
  • Tuberculous lymphadenitis must be considered, especially in endemic areas or with relevant exposure history, presenting as chronic painless lymphadenopathy 3
  • The minimal pain argues somewhat against acute bacterial infection but does not exclude subacute or chronic processes 3

Lymphangioma

  • Cystic lymphangiomas can present as soft, mobile axillary masses and, while typically diagnosed in infancy, can occasionally manifest later in childhood 4
  • These are malformations of lymphatic vessels that may enlarge in response to infection or inflammation 4
  • The 4 cm × 3 cm size is consistent with this diagnosis 4

Less Common Considerations

  • Lipoma: soft, mobile, painless subcutaneous masses that can occur in the axilla 3
  • Accessory axillary breast tissue: can present as soft axillary masses, though more common in females 3

Immediate Management Algorithm

Step 1: Clinical Assessment

  • Assess for systemic signs of bacterial infection: fever >38.5°C, significant tenderness, overlying erythema, or warmth 2
  • Evaluate the bronchiolitis severity: respiratory rate (tachypnea ≥70 breaths/minute indicates severe disease), work of breathing, and oxygen saturation 5, 6
  • Document exact size, consistency, mobility, and presence of fluctuance 1

Step 2: Supportive Care for Bronchiolitis

  • Provide supportive care only for the bronchiolitis—no bronchodilators, corticosteroids, or routine antibiotics 5, 6
  • Administer supplemental oxygen only if SpO₂ persistently falls below 90% 5, 7
  • Ensure adequate hydration; transition to IV fluids if respiratory rate exceeds 60-70 breaths/minute due to aspiration risk 7, 6

Step 3: Imaging Evaluation

  • Obtain targeted ultrasound of the axillary mass to characterize the lesion (solid vs. cystic, vascularity, internal architecture) 1
  • Ultrasound will differentiate between lymph nodes, lymphangioma, lipoma, or other soft tissue masses 1, 3
  • The chest X-ray showing bronchiolitis without other findings makes intrathoracic extension or malignancy less likely 2

Step 4: Observation vs. Intervention Decision Tree

If ultrasound shows typical reactive lymph nodes:

  • Observe for 4-6 weeks as the bronchiolitis resolves 2, 6
  • Reactive nodes should decrease in size as the viral illness clears 2
  • Re-examine at 2 weeks and 4-6 weeks post-illness 1

If ultrasound shows atypical features (loss of fatty hilum, round shape, abnormal vascularity) OR mass persists/enlarges:

  • Perform ultrasound-guided fine-needle aspiration (FNA) or core needle biopsy for definitive diagnosis 1
  • FNA is safe and accurate for guiding management in pediatric axillary masses 1
  • Send aspirate for bacterial culture, acid-fast bacilli (AFB) culture, and cytology 3

If ultrasound suggests lymphangioma (multiloculated cystic mass):

  • Surgical excision is the preferred treatment for lymphangiomas 4
  • Refer to pediatric surgery for definitive management 4

Critical Pitfalls to Avoid

  • Do not prescribe antibiotics for the bronchiolitis alone—serious bacterial infection rates are <1% in febrile infants with bronchiolitis, and the axillary mass is likely reactive 7, 6
  • Do not assume the mass is benign without imaging—while reactive lymphadenopathy is most likely, the 4 cm size warrants ultrasound evaluation to exclude other diagnoses 1
  • Do not biopsy immediately—allow 4-6 weeks for resolution after the bronchiolitis clears, as reactive nodes will regress spontaneously 1, 3
  • Do not overlook tuberculosis risk factors—obtain detailed exposure history and consider TB testing if the mass persists or the child has relevant epidemiologic risk 3

When to Escalate Care

  • Mass enlarges despite resolution of bronchiolitis 1
  • Development of systemic signs (high fever, night sweats, weight loss) suggesting infection or malignancy 3
  • Overlying skin changes, fluctuance, or significant pain develop, suggesting suppurative lymphadenitis requiring drainage 3
  • Mass persists unchanged at 6 weeks post-illness, warranting tissue diagnosis 1, 3

References

Research

A practical approach to imaging the axilla.

Insights into imaging, 2015

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

New-onset axillary lymphangioma: a case report.

Journal of medical case reports, 2022

Guideline

Bronquiolitis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Approach to Diagnosis and Management of Acute Bronchiolitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Bronchiolitis in Infants

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.